Fructose is known to be more lipogenic than glucose, and individuals with NAFLD have been shown to consume more fructose and have a higher hepatic mRNA expression of fatty acid synthase on their liver biopsy than non-NAFLD controls [47,48]. Here, FASN is linked to metabolic dysfunction-associated steatotic liver disease.